You have 0 free articles left this month.
Big Law

Bakers and Clutz advise on pharmaceutical offload (1)

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital) Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova…

January 11, 2012 • By Lawyers Weekly
Share this article on:
Facebook X LinkedIn
expand image

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital)

 
 

This content is available exclusively to Lawyers Weekly premium members.
Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova Pharmaceuticals from Ironbridge and Archer Capital. Deal officially closed on 21 December

Area: M&A

Value: $625 million upfront and up to an additional $75 million in potential milestones

Key players: The Bakers team was led by Sydney-based partner David Egan and associate Michael Dearden

Discover logo VIEW ALL

Want to see more stories from trusted news sources?
Make Lawyers Weekly a preferred news source on Google.
Click here to add Lawyers Weekly as a preferred news source.

Tags